Enzymatica AB (OSTO:ENZY) Days Sales Outstanding : 71.92 (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Enzymatica AB Days Sales Outstanding?

Enzymatica AB's average Accounts Receivable for the three months ended in Mar. 2025 was kr9.68 Mil. Enzymatica AB's Revenue for the three months ended in Mar. 2025 was kr12.28 Mil. Hence, Enzymatica AB's Days Sales Outstanding for the three months ended in Mar. 2025 was 71.92.

The historical rank and industry rank for Enzymatica AB's Days Sales Outstanding or its related term are showing as below:

OSTO:ENZY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.33 Med: 92.76 Max: 156.54
Current: 57.33

During the past 13 years, Enzymatica AB's highest Days Sales Outstanding was 156.54. The lowest was 57.33. And the median was 92.76.

OSTO:ENZY's Days Sales Outstanding is ranked better than
65.55% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs OSTO:ENZY: 57.33

Enzymatica AB's Days Sales Outstanding declined from Mar. 2024 (78.23) to Mar. 2025 (71.92).

Enzymatica AB Days Sales Outstanding Historical Data

The historical data trend for Enzymatica AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Days Sales Outstanding Chart

Enzymatica AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

78.85

156.54

113.90

91.68

93.83

Enzymatica AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															78.23	63.55	50.34	58.00	71.92

Competitive Comparison of Enzymatica AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzymatica AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Enzymatica AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Enzymatica AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (11.342	+	12.09)	/	2 )	/	45.575	*	365
=	11.716					/	45.575	*	365
=	93.83

Enzymatica AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (12.09	+	7.267)	/	2 )	/	12.28	*	365 / 4
=	9.6785					/	12.28	*	365 / 4
=	71.92

Enzymatica AB (OSTO:ENZY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Enzymatica AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymatica AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (OSTO:ENZY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70

Website

http://www.enzymatica.se

Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB Headlines

From GuruFocus

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016